Mymetics starts Research Project in Cancer Immunotherapy with IO Biotech
The original release is unavailable here.
Story so far
- Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
- Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA
- DGAP-News: Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
Earlier from Mymetics
- Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
- Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine
- Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes
- Mymetics receives HIV Vaccine Funding from the NIH
- Mymetics Receives Funding from NIH for Novel HIV Vaccine Study
Later from Mymetics
- Mymetics Reports Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergy Immunotherapy
- Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)
- Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
- Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine
- Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant
Follow Mymetics into a list and get an email when it puts out news.
Follow Mymetics